Translational Science Center Mission And Budget Draw Congress’ Scrutiny
This article was originally published in The Tan Sheet
Executive Summary
House Appropriations subcommittee Republicans seem concerned about whether the National Center for Advancing Translational Sciences will step on industry toes, which could lead to a more tightened focus for the new NIH center’s funding in the fiscal 2013 budget.
You may also be interested in...
Lilly In Collaboration To Screen NIH Pharmaceuticals Collection, Make Pharmacology Data Public
Repurposing opportunities are unlikely in this NCATS/Lilly project, which has the loftier goal of furthering understanding of how small molecule drugs actually work in complex human systems in order to improve drug development for the entire “research universe.”
Appropriations Negotiators Allow NIH Translational Science Center Launch
NIH receives more than $500 million to finance the National Center for Advancing Translational Science, created in the consolidated fiscal 2012 appropriations bill. Members of Congress cautioned that NCATS’ work to speed up drug development should not inhibit private efforts in the same arena.
DTC User Fees Rejected By House Approps Panel As FDA Safety Funds Get Boost
The House Appropriations Committee opted for using federal money, rather than fees from industry, to finance speedier FDA review of direct-to-consumer television ads when it approved a $1.7 billion fiscal year 2008 funding package for the agency July 19